Kelly Lim
11PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Jan 02, 2026
Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.Chloe A L Thompson-Peach, Daniel Thomas, Mara Dottore
|Sep 19, 2024
CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.Kelly Lim, Winnie L Kan, Pramod C Nair
|Mar 08, 2024
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.Lih En Hong, Mihir D Wechalekar, Monika Kutyna
|Jan 23, 2024
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation.Niklas Landberg, Thomas Köhnke, Yang Feng
|Dec 13, 2023
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation.Niklas Landberg, Thomas Köhnke, Yang Feng
|Nov 10, 2022
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability.Daniel Thomas, Manhong Wu, Yusuke Nakauchi
Pageof 2
Frequent Collaborators
7 joint publications
Daniel Thomas
6 joint publications
Chloe Thompson-Peach
5 joint publications
Ravindra Majeti
4 joint publications
Anna L Brown
4 joint publications
Devendra K Hiwase
4 joint publications
Nirmal Robinson
4 joint publications
Stuart Pitson
3 joint publications
Andreas Reinisch
3 joint publications
Monika M Kutyna
3 joint publications
Saumya E Samaraweera
